Marat Slessarev1,2,3, Ossama Mahmoud4, Christopher W McIntyre1,2, Christopher G Ellis2,5. 1. Department of Medicine, Western University, London, ON, Canada. 2. Department of Medical Biophysics, Western University, London, ON, Canada. 3. Brain & Mind Institute, Western University, London, ON, Canada. 4. Department of Computer Science, Western University, London, ON, Canada. 5. Robarts Research Institute, Western University, London, ON, Canada.
Abstract
Background: Ischemic and hyperemic injury have emerged as biologic mechanisms that contribute to cognitive impairment in critically ill patients. Spontaneous deviations in cerebral blood flow (CBF) beyond ischemic and hyperemic thresholds may represent an insult that contributes to this brain injury, especially if they accumulate over time and coincide with impaired autoregulation. Methods: We used transcranial Doppler to measure the proportion of time that CBF velocity (CBFv) deviated beyond previously reported ischemic and hyperemic thresholds in a cohort of critically ill patients with respiratory failure and/or shock within 48 h of ICU admission. We also assessed whether these CBFv deviations were more common during periods of impaired dynamic autoregulation, and whether they are explained by concurrent variations in mean arterial pressure (MAP) and end-tidal PCO2 (PetCO2). Results: We enrolled 12 consecutive patients (three females) who were monitored for a mean duration of 462.6 ± 39.8 min. Across patients, CBFv deviated by more than 20-30% from its baseline for 17-24% of the analysis time. These CBFv deviations occurred equally during periods of preserved and impaired autoregulation, while concurrent variations in MAP and PetCO2 explained only 13-21% of these CBFv deviations. Conclusion: CBFv deviations beyond ischemic and hyperemic thresholds are common in critically ill patients with respiratory failure or shock. These deviations occur irrespective of the state of dynamic autoregulation and are not explained by changes in MAP and CO2. Future studies should explore mechanisms responsible for these CBFv deviations and establish whether their cumulative burden predicts poor neurocognitive outcomes.
Background: Ischemic and hyperemic injury have emerged as biologic mechanisms that contribute to cognitive impairment in critically illpatients. Spontaneous deviations in cerebral blood flow (CBF) beyond ischemic and hyperemic thresholds may represent an insult that contributes to this brain injury, especially if they accumulate over time and coincide with impaired autoregulation. Methods: We used transcranial Doppler to measure the proportion of time that CBF velocity (CBFv) deviated beyond previously reported ischemic and hyperemic thresholds in a cohort of critically illpatients with respiratory failure and/or shock within 48 h of ICU admission. We also assessed whether these CBFv deviations were more common during periods of impaired dynamic autoregulation, and whether they are explained by concurrent variations in mean arterial pressure (MAP) and end-tidal PCO2 (PetCO2). Results: We enrolled 12 consecutive patients (three females) who were monitored for a mean duration of 462.6 ± 39.8 min. Across patients, CBFv deviated by more than 20-30% from its baseline for 17-24% of the analysis time. These CBFv deviations occurred equally during periods of preserved and impaired autoregulation, while concurrent variations in MAP and PetCO2 explained only 13-21% of these CBFv deviations. Conclusion: CBFv deviations beyond ischemic and hyperemic thresholds are common in critically illpatients with respiratory failure or shock. These deviations occur irrespective of the state of dynamic autoregulation and are not explained by changes in MAP and CO2. Future studies should explore mechanisms responsible for these CBFv deviations and establish whether their cumulative burden predicts poor neurocognitive outcomes.
Authors: David R Janz; Ty W Abel; James C Jackson; Max L Gunther; Stephan Heckers; E Wesley Ely Journal: J Crit Care Date: 2010-07-01 Impact factor: 3.425
Authors: Enrico Sorrentino; Karol P Budohoski; Magdalena Kasprowicz; Peter Smielewski; Basil Matta; John D Pickard; Marek Czosnyka Journal: Neurocrit Care Date: 2011-04 Impact factor: 3.210
Authors: D F Kelly; N A Martin; R Kordestani; G Counelis; D A Hovda; M Bergsneider; D Q McBride; E Shalmon; D Herman; D P Becker Journal: J Neurosurg Date: 1997-04 Impact factor: 5.115
Authors: Kimia Honarmand; Rajkamal S Lalli; Fran Priestap; Jennifer L Chen; Christopher W McIntyre; Adrian M Owen; Marat Slessarev Journal: Am J Respir Crit Care Med Date: 2020-02-20 Impact factor: 21.405
Authors: Tarek Sharshar; Robert Carlier; Francis Bernard; Céline Guidoux; Jean-Philippe Brouland; Olivier Nardi; Geoffroy Lorin de la Grandmaison; Jérôme Aboab; Françoise Gray; David Menon; Djillali Annane Journal: Intensive Care Med Date: 2007-03-22 Impact factor: 17.440
Authors: Patrick Schramm; Klaus Ulrich Klein; Lena Falkenberg; Manfred Berres; Dorothea Closhen; Konrad J Werhahn; Matthias David; Christian Werner; Kristin Engelhard Journal: Crit Care Date: 2012-10-04 Impact factor: 9.097
Authors: David Pfister; Martin Siegemund; Salome Dell-Kuster; Peter Smielewski; Stephan Rüegg; Stephan P Strebel; Stephan C U Marsch; Hans Pargger; Luzius A Steiner Journal: Crit Care Date: 2008-05-05 Impact factor: 9.097
Authors: Paulina M Kowalewska; Justin E Piazza; Stephanie L Milkovich; Richard J Sové; Lin Wang; Shawn N Whitehead; Christopher G Ellis Journal: Sci Rep Date: 2022-04-15 Impact factor: 4.996
Authors: Johanna Laurikkala; Anders Aneman; Alexander Peng; Matti Reinikainen; Paul Pham; Pekka Jakkula; Johanna Hästbacka; Erika Wilkman; Pekka Loisa; Jussi Toppila; Thomas Birkelund; Kaj Blennow; Henrik Zetterberg; Markus B Skrifvars Journal: Crit Care Date: 2021-09-28 Impact factor: 9.097